Zusammenfassung
Operationsziel
Ziel der Operation ist die Rekonstruktion segmentaler Knochensubstanzverluste des proximalen Femur nach weiter Tumorresektion oder nach Revisionseingriffen in der Hüftendoprothetik.
Indikationen
Aggressive benigne und primär maligne Knochentumoren des proximalen Femur, stabilitätsgefährdende Knochenmetastasen, ausgeprägter segmentaler Knochensubstanzverlust des proximalen Femur oder periprothetische Frakturen.
Kontraindikationen
Lokale floride Infektionen. Relative Kontraindikationen: Sehr kurze Lebenserwartung (< 3 Monate) und nicht vorhandenes azetabuläres Lager.
Operationstechnik
Anterolateraler Zugang, Darstellung und Ablösung des M. iliopsoas und des M. gluteus medius mit Sicherheitsabstand zum Knochen. Armierung der Sehnenstümpfe mit nichtresorbierbarem Nahtmaterial. Distale Durchtrennung von M. vastus lateralis, M. vastus intermedius und M. rectus femoris in Abhängigkeit der extraossären Tumorausdehnung. Distale Femurosteotomie mit Sicherheitsabstand von mindestens 3 cm zum Tumor. Bei totalem Femurersatz zusätzliche laterale Arthrotomie mit Resektion der Bänder und Menisken. Präparation des Markraums unter Schutz mit Verbrügge-Zange. Nach Probereposition mit Probekomponenten Implantation der definitiven Komponenten unter Einstellung der Antetorsion in 5°-Schritten. Vor Reposition Überstülpen und Fixieren eines Anbindungsschlauchs. Refixierung der Muskulatur am Anbindungsschlauch. Bei totalem Femurersatz Präparation des Tibiaschafts, Montage der Femurkomponenten und Kopplung mit der distalen Femurkomponente.
Weiterbehandlung
Infektionsprophylaxe, 20 kg Teilbelastung, Bewegungsschiene.
Ergebnisse
Von Juni 2007 bis Dezember 2011 erfolgte bei 20 Patienten die Implantation eines proximalen MUTARS®-Femurersatzes und bei 2 Patientinnen die Implantation eines totalen MUTARS®-Femurs. Das mittlere Alter zum Operationszeitpunkt betrug 62,0 ± 18,1 Jahre (18–82 Jahre). Die Operationsindikationen waren 3 primär maligne Knochentumore und 19 Femurmetastasen. Zum Zeitpunkt der Datenerhebung konnten 15 Patienten mit einem mittleren Nachuntersuchungszeitraum von 20,3 ± 17,2 Monaten (4–51 Monate) nachuntersucht werden. Bezogen auf alle 22 Fälle traten 3 tiefe Protheseninfektionen (13,6%) und 2 Luxationen (9,1%) auf. Von den 15 nachuntersuchten Patienten hatten 3 ein sehr gutes (20%), 4 ein gutes (26,7%), 6 ein zufriedenstellendes (40%) und 2 (13,3%) ein schlechtes funktionelles Ergebnis im MSTS-Score nach Enneking.
Abstract
Objective
Reconstruction of segmental bone defects of the proximal femur following wide tumor resection or revision arthroplasty.
Indications
Aggressive benign or primary malignant bone tumors of the proximal femur; destructive metastases; massive segmental bone defects of the proximal femur; periprosthetic fractures.
Contraindications
Local infection; very short life expectancy (< 3 months); massive deficiency of acetabular bone stock.
Operative technique
Anterolateral approach. Exposure and detachment of the iliopsoas and gluteus medius muscle from the proximal femur with a sufficient safety margin to the bone; distal transsection of the vastus lateralis/intermedius and rectus femoris muscle according to the extraosseous tumor extension; distal femur osteotomy al least 3 cm beyond the farthest point of tumor extension; in case of total femur replacement, additional lateral arthrotomy of the knee with resection of the ligaments and menisci; reaming of the medullary canal after securing the shaft with a Verbrugge clamp; trial assembly and reduction followed by the definitive implantation of the prosthesis with adjustment of the femoral neck anteversion in 5° increments; soft tissue reconstruction and fixation to an attachment tube covering the prosthesis; in case of total femur replacement, the preparation of the tibia is followed by the coupling of the tibial and femoral components.
Postoperative management
Infection prophylaxis, 20 kg partial weight bearing, continuous passive motion.
Results
A total of 20 patients with proximal femur replacement and 2 patients with total femur replacement implanted between June 2007 and December 2011 were retrospectively reviewed. Three patients had primary malignant bone tumors, while 19 patients underwent resection for metastatic disease. The mean age at surgery was 62.0 ± 18.1 years (18–82 years). Fifteen patients with a mean follow-up of 20.3 ± 17.2 months (4–51 months) were studied. Among the 22 cases, periprosthetic infection occurred in 3 patients (13.6%), dislocation in 2 patients (9.1%). Evaluation of the functional outcome in 15 patients using the MSTS score by Enneking revealed 3 very good (20%), 4 good (26.7%), 6 fair (40%), and 2 poor (13.3%) results.
Literatur
Althausen P, Althausen A, Jennings LC et al (1997) Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer 80:1103–1109
Ascherl R (2010) Infection management of megaimplants. Orthopade 39:980–993
Berbari EF, Hanssen AD, Duffy MC et al (1998) Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 27:1247–1254
Bickels J, Jelinek JS, Shmookler BM et al (1999) Biopsy of musculoskeletal tumors. Current concepts. Clin Orthop Relat Res 368:212–219
Bickels J, Meller I, Henshaw RM et al (2000) Reconstruction of hip stability after proximal and total femur resections. Clin Orthop Relat Res 375:218–230
Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776–790
Chandrasekar CR, Grimer RJ, Carter SR et al (2008) Modular endoprosthetic replacement for metastatic tumours of the proximal femur. J Orthop Surg Res 3:50
Della Valle CJ, Paprosky WG (2003) Classification and an algorithmic approach to the reconstruction of femoral deficiency in revision total hip arthroplasty. J Bone Joint Surg Am 85-A(Suppl 4):1–6
Dürr HR, Refior HJ (1998) Prognosis of skeletal metastases. Orthopade 27:294–300
Enneking WF, Dunham W, Gebhardt M et al (1990) A system for the classification of skeletal resections. Chir Organi Mov 75:217–240
Enneking WF, Dunham W, Gebhardt M et al (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 286:241–246
Fottner A, Szalantzy M, Wirthmann L et al (2010) Bone metastases from renal cell carcinoma: patient survival after surgical treatment. BMC Musculoskelet Disord 11:145
Fox EJ, Hau MA, Gebhardt MC et al (2002) Long-term follow-up of proximal femoral allografts. Clin Orthop Relat Res 397:106–113
Gebhardt MC, Flugstad DI, Springfield DS et al (1991) The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. Clin Orthop Relat Res 270:181–196
Gosheger G, Gebert C, Ahrens H et al (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 450:164–171
Gosheger G, Goetze C, Hardes J et al (2008) The influence of the alloy of megaprostheses on infection rate. J Arthroplasty 23:916–920
Gosheger G, Hillmann A, Lindner N et al (2001) Soft tissue reconstruction of megaprostheses using a trevira tube. Clin Orthop Relat Res 393:264–271
Grimer RJ, Belthur M, Chandrasekar C et al (2002) Two-stage revision for infected endoprostheses used in tumor surgery. Clin Orthop Relat Res 395:193–203
Heisel C, Kinkel S, Bernd L et al (2006) Megaprostheses for the treatment of malignant bone tumours of the lower limbs. Int Orthop 30:452–457
Jeys LM, Grimer RJ, Carter SR et al (2005) Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am 87:842–849
Jeys LM, Kulkarni A, Grimer RJ et al (2008) Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am 90:1265–1271
Kabukcuoglu Y, Grimer RJ, Tillman RM et al (1999) Endoprosthetic replacement for primary malignant tumors of the proximal femur. Clin Orthop Relat Res 358:8–14
Lin PP, Mirza AN, Lewis VO et al (2007) Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am 89:1794–1801
Mankin HJ (2003) The changes in major limb reconstruction as a result of the development of allografts. Chir Organi Mov 88:101–113
McDonald DJ, Capanna R, Gherlinzoni F et al (1990) Influence of chemotherapy on perioperative complications in limb salvage surgery for bone tumors. Cancer 65:1509–1516
Menendez LR, Ahlmann ER, Kermani C et al (2006) Endoprosthetic reconstruction for neoplasms of the proximal femur. Clin Orthop Relat Res 450:46–51
Mittermayer F, Windhager R, Dominkus M et al (2002) Revision of the Kotz type of tumour endoprosthesis for the lower limb. J Bone Joint Surg Br 84:401–406
Morris HG, Capanna R, Campanacci D et al (1994) Modular endoprosthetic replacement after total resection of the femur for malignant tumour. Int Orthop 18:90–95
Palumbo BT, Henderson ER, Groundland JS et al (2011) Advances in segmental endoprosthetic reconstruction for extremity tumors: a review of contemporary designs and techniques. Cancer Control 18:160–170
Sharma S, Turcotte RE, Isler MH et al (2007) Experience with cemented large segment endoprostheses for tumors. Clin Orthop Relat Res 459:54–59
Unni K (1996a) Chondrosarcoma primary, secondary, dedifferentiated, and clear cell. In: Unni K (Hrsg) Dahlin’s bone tumor. General aspects and data on 11,987 cases. JB Lippincott, Philadelphia S 71–108
Unni K (1996b) Ewing-Tumor. In: Unni K (Hrsg) Dahlin’s bone tumor. General aspects and data on 11,987 cases. JB Lippincott, Philadelphia, S 249–261
Unni K (1996c) Osteosarcoma. In: Unni K (Hrsg) Dahlin’s bone tumor. General aspects and data on 11,987 Cases. JB Lippincott, Philadelpia, S 143–183
Unwin PS, Cannon SR, Grimer RJ et al (1996) Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. J Bone Joint Surg Br 78:5–13
Winkelmann W (2010) Reconstruction of the proximal femur with the MUTARS(R) system. Orthopade 39:942–948
Zeegen EN, Aponte-Tinao LA, Hornicek FJ et al (2004) Survivorship analysis of 141 modular metallic endoprostheses at early follow-up. Clin Orthop Relat Res 420:239–250
Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645–1654
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pennekamp, P., Wirtz, D. & Dürr, H. Der proximale und komplette Femurersatz. Oper Orthop Traumatol 24, 215–226 (2012). https://doi.org/10.1007/s00064-011-0061-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00064-011-0061-7